Primary Care Medicine: On Demand 3.2
|
$500.00
Use promo code (Limited Offer)
20 CREDITS
 |
|
A collection of recorded video lectures from conferences that took place in 2019Course Content
| Session | Title | Faculty |
| Session 1 (66 minutes) | Basal Insulin and GLP-1RA’s: Factors to Consider as First and Combination Therapy | Laura A. Young, MD, PhD |
| Session 2 (59 minutes) | Glucose Monitoring in 2019 and Beyond | Laura A. Young, MD, PhD |
| Session 3 (57 minutes) | Managing Chronic Kidney Disease in Primary Care | Matthew R. Weir, MD |
| Session 4 (61 minutes) | Drug Safety in Chronic Kidney Disease | Matthew R. Weir, MD |
| Session 5 (54 minutes) | Challenging Cases in Dermatology | Richard P. Usatine, MD |
| Session 6 (72 minutes) | Cardiovascular Risk Reduction In Diabetes | Jay H. Shubrook, DO |
| Session 7 (46 minutes) | Diabetes on a Budget | Jay H. Shubrook, DO |
| Session 8 (66 minutes) | Cancer in Primary Care | David Sadava, PhD |
| Session 9 (52 minutes) | DNA Primary Care | David Sadava, PhD |
| Session 10 (54 minutes) | Case Studies in Women’s Health: Pearls & Perils for Every Clinician | David M. Plourd, MD |
| Session 11 (63 minutes) | Dermatology Update | Eddie Needham, MD FAAFP |
| Session 12 (58 minutes) | Asthma in Adults | Eddie Needham, MD FAAFP |
| Session 13 (62 minutes) | Updates in Outpatient Chronic Liver Disease Management, Part I (NAFLD, HBV, HCV) | Christopher M. Moore, MD |
| Session 14 (65 minutes) | Updates in Outpatient Chronic Liver Disease Management, Part II (Alcohol Use Disorder, Cirrhosis, MELD Score and Frailty) | Christopher M. Moore, MD |
| Session 15 (65 minutes) | Gout: Keep It Simple, Stupid | Clarence W. Legerton, MD |
| Session 16 (53 minutes) | Cases in Rheumatology | Clarence W. Legerton, MD |
| Session 17 (61 minutes) | Atrial Fibrillation | Scott Kaatz, DO |
| Session 18 (64 minutes) | Venous Thromboembolism (VTE) Disease | Scott Kaatz, DO |
| Session 19 (59 minutes) | Primary Care Guide to Palliative Care | Jim F. Cleary, MD |
| Session 20 (54 minutes) | Communication Skills in Palliative Care | Jim F. Cleary, MD |
Program Overview
Presented by Continuing Education Company (CEC) for the past 26 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from conferences that took place in 2019. The emphasis of this course is on practical and useful information for clinical practice.
This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category 1 credit for completing this activity.
AANPCP: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Release Date: 10/23/2019
Expiration Date: 10/23/2022
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Ronald Jendry, MD - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Jim F. Cleary, MD | Nothing to Disclose |
| Scott Kaatz, DO | Advisory Board, Consultant: Bristol Myer Squibb and Roche Advisory Board, Consultant, Research Grant: Janssen Consultant: Pfizer Advisory Board: Portola |
| Clarence W. Legerton, MD | Research Grant: AbbVie, AstraZeneca, Corrona-Registry, Eli-Lilly, Gilead, INFLARx, Ironwood, Nichi-lko, Novartis, Pfizer, Regeneron, R-Pharm, TissueGene, and UCB |
| Christopher M. Moore, MD | Nothing to disclose |
| Eddie Needham, MD FAAFP | Nothing to disclose |
| David M. Plourd, MD | Nothing to disclose |
| David Sadava, PhD | Nothing to disclose |
| Jay H. Shubrook, DO | Rsearch Grant: Eli Lilly and Sanofi Advisory Board: Intarcia Therapeutics, Lilly Diabetes, and Novo Nordisk |
| Richard P. Usatine, MD | Nothing to Disclose |
| Matthew R. Weir, MD | Advisory Board: Astra, Bayer,Boehringer-Ingelheim, Boston Scientific, Janssen, Lexicon, MSD, Relypsa, and Vifor Pharma Grant Recipient: NIDDK: R01DK 066013, NHLBI: R01HL127422 and U01DK106102 Research Grant: R01HL132732 and U01DK116095 |
| Laura A. Young, MD, PhD | Consultant, Grant Recipient, Research Grant: Bayer Consultant, Grant Recipient (Paid by UNC), Research Grant: BMS and Lexicon Research Grant: Boehringer-Ingelheim, Theracos, and vTv Pharma Consultant: Dexcom Grant Recipient (Paid by UNC), Research Grant: Novo Nordisk and Sanofi |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships which they or their spouse/partner have with (a) with the manufacturer(s) of any commercial products(s) and/or provider(s) of commercial services discussed in an educational presentation and (b) with any commercial supporters of the activity. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All potential conflicts of interest have been identified and resolved, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration-info@cmemeeting.org within 30 days of the purchase date for a full refund. Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.